483
Orthofix U.S. LLCFDA 483 - Orthofix U.S. LLC - March 17, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Orthofix U.S. LLC in Lewisville, TX, revealed significant deficiencies in their quality system. The firm failed to adequately evaluate and investigate customer complaints for their Class III AccelStim Bone Growth Stimulator, even when device failures were reported. Additionally, the company's corrective and preventive action (CAPA) procedures were not adequately established, leading to a lack of investigation into numerous device issues.
Open in Dashboard
ID · 266a0522-b819-470b-b94e-9cc39dc2af03